Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

New medicines: human

Get the latest updates from New medicines: human directly as they happen.

Follow now 400 followers

Latest posts

Last updated 8 days ago

Human medicines European public assessment report (EPAR): Obodence, denosumab, Status: Opinion

8 days ago

Human medicines European public assessment report (EPAR): Obodence, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR): Xbryk, denosumab, Status: Opinion

8 days ago

Human medicines European public assessment report (EPAR): Xbryk, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR): Lazcluze, lazertinib, Status: Opinion

8 days ago

Human medicines European public assessment report (EPAR): Lazcluze, lazertinib, Status: Opinion

Human medicines European public assessment report (EPAR): Gohibic, vilobelimab, Status: Opinion

8 days ago

Human medicines European public assessment report (EPAR): Gohibic, vilobelimab, Status: Opinion

Human medicines European public assessment report (EPAR): Augtyro, repotrectinib, Status: Opinion

8 days ago

Human medicines European public assessment report (EPAR): Augtyro, repotrectinib, Status: Opinion

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Status: Opinion

8 days ago

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Status: Opinion

Human medicines European public assessment report (EPAR): Kizfizo, temozolomide, Status: Opinion

8 days ago

Human medicines European public assessment report (EPAR): Kizfizo, temozolomide, Status: Opinion

Human medicines European public assessment report (EPAR): Baiama, aflibercept, Status: Opinion

12 days ago

Human medicines European public assessment report (EPAR): Baiama, aflibercept, Status: Opinion

Human medicines European public assessment report (EPAR): Fluad, influenza vaccine (surface antigen, inactivated, adjuvanted), Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Fluad, influenza vaccine (surface antigen...

Human medicines European public assessment report (EPAR): Buprenorphine Neuraxpharm, buprenorphine, Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Buprenorphine Neuraxpharm, buprenorphine, Status: Opinion

Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Status: Opinion